Advantech Capital Investment I Limited - Net Worth and Insider Trading
Advantech Capital Investment I Limited Net Worth
The estimated net worth of Advantech Capital Investment I Limited is at least $128 Million dollars as of 2024-06-21. Advantech Capital Investment I Limited is the of Alphamab Oncology and owns about 49,691,190 shares of Alphamab Oncology (HKSE:09966) stock worth over $128 Million. Details can be seen in Advantech Capital Investment I Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Advantech Capital Investment I Limited has not made any transactions after 2019-12-12 and currently still holds the listed stock(s).
Transaction Summary of Advantech Capital Investment I Limited
Advantech Capital Investment I Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Advantech Capital Investment I Limited owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .
Insider Ownership Summary of Advantech Capital Investment I Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 |
Advantech Capital Investment I Limited Latest Holdings Summary
Advantech Capital Investment I Limited currently owns a total of 1 stock. Advantech Capital Investment I Limited owns 49,691,190 shares of Alphamab Oncology (HKSE:09966) as of December 12, 2019, with a value of $128 Million.
Latest Holdings of Advantech Capital Investment I Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 | 49,691,190 | 2.58 | 128,203,270 |
Holding Weightings of Advantech Capital Investment I Limited
Advantech Capital Investment I Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Advantech Capital Investment I Limited has made a total of 1 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on December 12, 2019, which brought Advantech Capital Investment I Limited around $0.
Insider Trading History of Advantech Capital Investment I Limited
- 1
Advantech Capital Investment I Limited Trading Performance
Advantech Capital Investment I Limited Ownership Network
Advantech Capital Investment I Limited Owned Company Details
What does Alphamab Oncology do?
Who are the key executives at Alphamab Oncology?
Advantech Capital Investment I Limited is the of Alphamab Oncology. Other key executives at Alphamab Oncology include 2301 Trustee South Dakota Trust Company Llc , 2305 Beneficiary of a trust Xu Ting , and 2307 Founder of a discretionary trust who can infl LIU YANG .
Alphamab Oncology (HKSE:09966) Insider Trades Summary
Over the past 18 months, Advantech Capital Investment I Limited made no insider transaction in Alphamab Oncology (HKSE:09966). Other recent insider transactions involving Alphamab Oncology (HKSE:09966) include a net sale of 0 shares made by Xu Ting , a net sale of 0 shares made by South Dakota Trust Company Llc , and a net sale of 0 shares made by LIU YANG .
In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alphamab Oncology Insider Transactions
Advantech Capital Investment I Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Advantech Capital Investment I Limited. Currently GuruFocus does not have mailing address information for Advantech Capital Investment I Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
